Clinical trials: Reaching
Hilar Cholangiocarcinoma, Duodenal Neoplasms
Diagnostic Accuracy of Eus Fnb in Difficult to Reach Lesions
The present study aims at comprehensively assessing the diagnostic performance and safety profile of EUS-FNB as a primary diagnostic tool for suspected malignancies in anatomically complex or deeply situated regions, including…
- Trial name
- NCT07621536
- Where
- Italy
- Volunteers
- 131 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Oppositional Defiant Disorder, Conduct Disorder
Resources to Enhance the Adjustment of Children (REACH)
This continuation study evaluates the long-term outcomes of multimodal, modular interventions with early-onset behavior disordered children and innovative methods to promote the maintenance and extension of treatment effects…
- Conditions
- Oppositional Defiant Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder
- Trial name
- REACH (NCT00820001)
- Testing
- Booster Treatment, No-Booster, No intervention
- Where
- 2 sites in United States
- Volunteers
- 254 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh
HIV Infections, Pregnancy Related
Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ
"SKILLZ," is a mixed methods evaluation of the Grassroots Soccer (GRS) SKILLZ Package based in Lusaka, Zambia. The package is made up of three football-based programs: (1) SKILLZ-Girl - implemented in schools as part of a 10-week…
- Conditions
- HIV Infections, Pregnancy Related, STI, Mental Health Wellness 1
- Trial name
- SKILLZ (NCT04429061)
- Testing
- SKILLZ-Girl curriculum
- Where
- Zambia
- Volunteers
- 2,153 people, healthy volunteers welcome
- Sponsor
- University of Alabama at Birmingham
Gestational Diabetes Mellitus, Type 2 Diabetes Mellitus
Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes
The purpose of the STAR-MAMA intervention is to develop a patient-tailored telephone-base counseling intervention for young Latino women who are at high risk of diabetes.
- Trial name
- Star-Mama (NCT02240420)
- Testing
- Life Style Counseling (Star-Mama)
- Where
- United States
- Volunteers
- 181 people
- Sponsor
- University of California, San Francisco
HIV Infection
Reaching Persons With HIV Who Are Out of Care Through Expedited Access to Long-Acting Injectable Antiretroviral Therapy - The RELAI Study
Purpose: The purpose of this study is to evaluate the acceptability of field-based long acting cabotegravir/rilpivirine (LA-CAB/RPV) among people with HIV (PWH) who are out of care.
- Trial name
- NCT07895823
- Testing
- Field-based LA-CAB/RPV
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of North Carolina, Chapel Hill
Aged, Acute Disease
Evaluation of a Residential In-Reach Program in Regional and Rural Australia
Residential In-Reach (RIR) programs are designed to provide responsive care for residents in residential aged care homes (RACH) with the aim of avoiding unnecessary hospital transfers.
- Trial name
- NCT06901167
- Testing
- Residential In-Reach Program
- Where
- 8 sites in Australia
- Volunteers
- 100 people
- Sponsor
- Monash University
Breast Cancer
The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).
- Trial name
- NCT03980093
- Testing
- Education, Values
- Where
- United States
- Volunteers
- 88 people, healthy volunteers welcome
- Sponsor
- University of Colorado, Boulder
Gastroesophageal Reflux Disease, Excessive Weight Loss
Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients
Gastroesophageal reflux disease (GERD) is one of the most common chronic conditions that can affect one's quality of life. Laparoscopic sleeve gastrectomy (LSG) has become a popular technique and currently is the most frequently…
- Conditions
- Gastroesophageal Reflux Disease, Excessive Weight Loss, Total Weight Loss, Sleeve Gastrectomy
- Trial name
- SG-REACH (NCT05452980)
- Testing
- reestablishment of the acute angle of His, sleeve gastrectomy
- Where
- China
- Volunteers
- 66 people
- Sponsor
- Zhen Jun Wang
Heart Failure
Home-based Cardiac Rehabilitation for People Living With Heart Failure and Their Caregivers- The DK:REACH-HF Pilot Study
Background: Participation in cardiac rehabilitation (CR) is a strong recommendation of clinical guidelines for the management of heart failure (HF) because it is demonstrated to be a clinically effective and cost-effective…
- Trial name
- NCT06573242
- Testing
- Home-based cardiac rehabilitation for people living with Heart Failure and their caregivers
- Where
- 2 sites in Denmark
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- Herlev and Gentofte Hospital
HIV Infections, Smoking
Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
This project will compare the effectiveness of an HIV-specific comprehensive wellness intervention designed to have broad appeal to smokers living with HIV to the effectiveness of standard care services that include referral to…
- Conditions
- HIV Infections, Smoking, Smoking Cessation
- Trial name
- WISH (NCT04505371)
- Testing
- Wellness Intervention for Smokers with HIV
- Where
- United States
- Volunteers
- 235 people, healthy volunteers welcome
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
Anxiety Disorders, Substance Use Disorders
Expanding Reach of Evidence-based Psychotherapy for Veterans With Co-occurring Anxiety and Substance Use Disorders.
The current study seeks to better understand how to improve access to evidence-based psychotherapy (EBP) for rural Veterans with co-occurring anxiety and substance use disorders (SUD) using a web-based cognitive behavioral…
- Trial name
- NCT05372185
- Testing
- VA Coordinated Anxiety Learning and Management- Substance Use Version, Usual care
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Baylor College of Medicine
Atheroscleroses, Coronary
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
High-dose statins can reduce mortality and cardiovascular events in patients with established atherosclerotic cardiovascular disease (ASCVD).
- Trial name
- NCT04826354
- Testing
- Rosuvastatin and Ezetimibe, Rosuvastatin
- Where
- 2 sites in South Korea
- Volunteers
- 582 people
- Sponsor
- Korea University Anam Hospital
STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
AMUNDSEN-real is a phase IV, international (7 European countries), multicenter, controlled, open label study randomized, in 2 parallel groups of patients with a diagnosis of STEMI or NSTEMI with an indication for PCI, using the…
- Trial name
- AMUNDSEN (NCT04951856)
- Testing
- Evolocumab 140 MG/ML, Standard of care (SOC)
- Where
- France
- Volunteers
- 2,166 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Congenital Hearing Loss
Communities Helping the Hearing of Infants by Reaching Parents
Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many…
- Trial name
- CHHIRP (NCT03875339)
- Testing
- Navigator Guidance
- Where
- 2 sites in United States
- Volunteers
- 2,699 people, healthy volunteers welcome
- Sponsor
- Matthew Bush, MD
ULCERATIVE COLITIS
Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET
PHASE: IV TYPE OF STUDY: With direct benefit DESCRIPTIVE: multicenter, open-label, uncontrolled trial INCLUSION CRITERIA: Adults with moderate to severe ulcerative colitis who failed corticosteroids and immunosupressive therapy…
- Trial name
- In-TARGET (NCT02425865)
- Testing
- GOLIMUMAB
- Where
- 23 sites in Belgium, France
- Volunteers
- 202 people
- Sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Pregnant Women
Goals for Reaching Optimum Wellness (GROWell)
This is a pilot study to assess the feasibility, acceptability and preliminary efficacy of the GROWell diet intervention. The objective of this study is to determine whether the GROWell intervention can help transition women from…
- Trial name
- NCT02904473
- Testing
- GROWell
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- Duke University
Parkinson Disease
Deep Brain Stimulation (DBS) for Parkinson's Disease International Study
To gather data on DBS Therapy effectiveness in different geographic populations.
- Trial name
- REACH-PD (NCT02937688)
- Testing
- Medtronic DBS Therapy for Parkinson's disease
- Where
- 15 sites in Brazil, China
- Volunteers
- 212 people
- Sponsor
- MedtronicNeuro
Diabetes
Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes
The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes.
- Trial name
- TARGIT-DM (NCT02846779)
- Testing
- Low intensity, Moderate intensity, High intensity
- Where
- United States
- Volunteers
- 6,000 people
- Sponsor
- Brigham and Women's Hospital
Diabetes Mellitus Type 2, Hyperglycemia
Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
The aim of the investigators study was to compare for the first time efficacy and safety of intravenously administered GLP-1 with an established intravenous insulin regimen in hyperglycaemic type 2 diabetic patients.
- Trial name
- NCT00859079
- Testing
- GLP-1, Human regular insulin intravenously
- Where
- Austria
- Volunteers
- 8 people
- Sponsor
- Medical University of Graz
Point-of-Care Testing, HIV
Ayaangwaamiziwin Initiative: Carefulness and Preparedness
The goal of this clinical trial is to implement a test, treat, and connect intervention approach using HIV and syphilis rapid point-of-care (POC) testing in 3 Canadian Prairie provinces (Alberta, Manitoba, and Saskatchewan)…
- Conditions
- Point-of-Care Testing, HIV, Syphilis
- Trial name
- AI (NCT06893159)
- Testing
- INSTI HIV-1/2 Antibody Test, INSTI Multiplex HIV-1/2 Syphilis Antibody Test, Multiplo Complete Syphilis (TP/nTP) Antibody Test
- Where
- 8 sites in Canada
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Unity Health Toronto